Jingyi Tang Selected Research

Jingyi Tang Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 01/2021
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2022
3	Malaria 10/2023 - 11/2020
3	Inflammation (Inflammations) 04/2023 - 01/2023
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2023 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2022
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2021
2	Colitis 02/2024 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2021
2	Pain (Aches) 01/2024 - 01/2020
2	Atrophy 10/2023 - 01/2022
2	Cognitive Dysfunction 10/2023 - 01/2022
2	Chronic Renal Insufficiency 04/2023 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Heart Failure 01/2022 - 01/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 01/2020
1	Keratosis 04/2024
1	Drug-Related Side Effects and Adverse Reactions 03/2024
1	Ulcerative Colitis 02/2024
1	Body Weight (Weight, Body) 02/2024
1	Cancer Pain 01/2024
1	Alzheimer Disease (Alzheimer's Disease) 10/2023
1	Sarcopenia 10/2023
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 10/2023
1	Hypoxia (Hypoxemia) 04/2023
1	Familial paroxysmal dystonia 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Epilepsy (Aura) 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Lewis Lung Carcinoma 02/2022
1	Myocardial Infarction 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021

Drug/Important Bio-Agent (IBA)

3	artenimol (dihydroartemisinin)IBA 04/2024 - 01/2022
3	artemisinin (artemisinine)IBA 04/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 10/2023 - 02/2023
2	IronIBA 04/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 03/2023 - 02/2023
2	ChemokinesIBA 01/2023 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2022
2	CanagliflozinIBA 01/2022 - 01/2021
2	NAD (NADH)IBA 01/2020 - 01/2020
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 04/2024
1	upadacitinibIBA 04/2024
1	Glutamine (L-Glutamine)FDA Link 03/2024
1	gegenqinlianIBA 02/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2024
1	Transcription Factors (Transcription Factor)IBA 02/2024
1	Hematoxylin (Haematoxylon)IBA 02/2024
1	NLR ProteinsIBA 02/2024
1	InflammasomesIBA 02/2024
1	ChromatinIBA 10/2023
1	HeterochromatinIBA 10/2023
1	Pemetrexed (MTA)FDA Link 10/2023
1	tongluoIBA 10/2023
1	Branched-Chain Amino AcidsIBA 10/2023
1	HematinicsIBA 04/2023
1	C-Reactive ProteinIBA 04/2023
1	Prolyl-Hydroxylase InhibitorsIBA 04/2023
1	roxadustatIBA 04/2023
1	Tyrosine Kinase InhibitorsIBA 03/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	CytokinesIBA 01/2023
1	Chemokine ReceptorsIBA 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	docosahexaenoylascorbic acid (DHA-As)IBA 02/2022
1	CreatinineIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	empagliflozinIBA 01/2022
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2022
1	ArtesunateIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	dapagliflozinIBA 01/2022
1	SymportersIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	SodiumIBA 01/2022
1	ertugliflozinIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	AgarIBA 02/2021
1	AntigensIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	PlatinumIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Sulfonic AcidsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	phenazine FDA Link 01/2021

Therapy/Procedure

7	Therapeutics 03/2024 - 01/2021
4	Immunotherapy 01/2024 - 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024
1	Acupuncture Points (Acupuncture Point) 01/2024
1	Moxibustion 10/2023
1	Drug Therapy (Chemotherapy) 01/2021